{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:46:55Z","timestamp":1790930815996,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bpg.2011.09.011","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T11:24:47Z","timestamp":1322652287000},"page":"689-700","source":"Crossref","is-referenced-by-count":32,"title":["Autoimmune hepatitis in special patient populations"],"prefix":"10.1016","volume":"25","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.09.011_bib1","first-page":"313","article-title":"Diverse manifestations and evolving treatments of autoimmune hepatitis","volume":"51","author":"Czaja","year":"2005","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.bpg.2011.09.011_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0029-1233530","article-title":"Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients","volume":"29","author":"Czaja","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.09.011_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","article-title":"Difficult treatment decisions in autoimmune hepatitis","volume":"16","author":"Czaja","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","author":"Nikias","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib5","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","author":"Singh","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.09.011_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib12","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3748\/wjg.15.2314","article-title":"Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment","volume":"15","author":"Czaja","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","article-title":"Autoimmune hepatitis in the elderly","volume":"96","author":"Schramm","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Verslype","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.09.011_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib17","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","article-title":"Current and future treatments of autoimmune hepatitis","volume":"3","author":"Czaja","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib20","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s10620-009-1122-8","article-title":"Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-200825030-00005","article-title":"Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly","volume":"25","author":"Czaja","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bpg.2011.09.011_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","article-title":"Management and outcome of pregnancy in autoimmune hepatitis","volume":"48","author":"Heneghan","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.09.011_bib23","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery","volume":"97","author":"Buchel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14740338.7.3.319","article-title":"Safety issues in the management of autoimmune hepatitis","volume":"7","author":"Czaja","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bpg.2011.09.011_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib27","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-199506000-00010","article-title":"Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations","volume":"19","author":"Burgart","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2011.09.011_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpg.2011.09.011_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1872-034X.2007.00125.x","article-title":"Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis","volume":"37","author":"Miyake","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2011.09.011_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2011.09.011_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2011.09.011_bib33","first-page":"303","article-title":"Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis","volume":"57","author":"Davis","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2011.09.011_bib34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1872-034X.2008.00347.x","article-title":"Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis","volume":"38","author":"Iwai","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2011.09.011_bib35","first-page":"1233","article-title":"Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases","volume":"52","author":"Kanda","year":"2005","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.09.011_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.09.011_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib42","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Practice Guidelines of the American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-011-1769-9","article-title":"Cryptogenic chronic hepatitis and its changing guise in adults","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib47","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","author":"Montano-Loza","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.09.011_bib48","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib49","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2006-927280","article-title":"Steroid treatment for severe acute cryptogenic hepatitis","volume":"45","author":"Potthoff","year":"2007","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","author":"Heringlake","year":"2009","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2011.09.011_bib55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","author":"Kenny","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib60","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","article-title":"Autoimmune hepatitis and its variant syndromes","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.09.011_bib61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib63","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib64","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.09.011_bib65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib66","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib67","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib68","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib69","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib70","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.22223","article-title":"Racial disparity in liver disease: biological, cultural, or socioeconomic factors","volume":"47","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2007.12.048","article-title":"Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis","volume":"6","author":"Czaja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.09.011_bib72","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy","volume":"96","author":"Lim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib73","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib74","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","article-title":"HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients","volume":"103","author":"Seki","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.09.011_bib77","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","article-title":"Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1\u22171301) haplotype","volume":"41","author":"Fainboim","year":"1994","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bpg.2011.09.011_bib78","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib79","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","article-title":"Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB\u22171301, a marker for pediatric autoimmune hepatitis","volume":"33","author":"Fainboim","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib80","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0140-6736(91)92858-Y","article-title":"Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals","volume":"337","author":"Vento","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.09.011_bib81","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1572-0241.2008.02022.x","article-title":"Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999\u20132004","volume":"103","author":"Flores","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib82","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.21580","article-title":"Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study","volume":"45","author":"Nguyen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib83","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1023\/A:1018836004279","article-title":"Immune phenotype of chronic liver disease","volume":"43","author":"Czaja","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib84","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.500060225","article-title":"Fetal microchimerisms in the mother: immunologic implications","volume":"6","author":"Tanaka","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.09.011_bib85","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib86","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.283.5406.1277","article-title":"A gender gap in autoimmunity","volume":"283","author":"Whitacre","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpg.2011.09.011_bib87","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.09.011_bib88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hepres.2006.06.007","article-title":"Clinical characteristics of autoimmune hepatitis in older aged patients","volume":"36","author":"Miyake","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2011.09.011_bib89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/qjmed\/90.4.289","article-title":"Type I autoimmune hepatitis is primarily a disease of later life","volume":"90","author":"Parker","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.bpg.2011.09.011_bib90","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/BF01309511","article-title":"Autoimmune chronic active hepatitis in postmenopausal women","volume":"30","author":"Lebovics","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.09.011_bib91","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/lt.21181","article-title":"Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival","volume":"13","author":"Cross","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2011.09.011_bib92","first-page":"71","article-title":"T-cell function in aging: mechanisms of decline","volume":"10","author":"Murasko","year":"1990","journal-title":"Annu Rev Gerontol Geriatr"},{"key":"10.1016\/j.bpg.2011.09.011_bib93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9378(67)90503-0","article-title":"Azathioprine (Imuran) and pregnancy","volume":"97","author":"Rosenkrantz","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpg.2011.09.011_bib94","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","author":"de Boer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.09.011_bib95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semarthrit.2005.03.002","article-title":"Autoimmune hepatitis and pregnancy: a rheumatologist\u2019s dilemma","volume":"35","author":"Candia","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bpg.2011.09.011_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1665-2681(19)32008-3","article-title":"Pregnancy and autoimmune hepatitis","volume":"5","author":"Uribe","year":"2006","journal-title":"Ann Hepatol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T22:52:56Z","timestamp":1593298376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521691811000886"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.09.011","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}